Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

It is always worth paying attention when someone wins a Nobel Prize for their life’s work, but a couple of awards this year ...

Fisher Asset Management's portfolio value increased to $244B, with top holdings in Apple, Microsoft, Nvidia, Amazon, and ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

People with chronic kidney disease, Type 2 diabetes or both were predicted to have elevated cardiovascular disease (CVD) risk 8 to 28 years sooner than someone without those conditions, according to a ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

While some GLP-1s are approved for patients age 12 and older, only a few telehealth companies will prescribe them to children ...